HKSE - Delayed Quote HKD

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK)

Compare
3.640 -0.110 (-2.93%)
At close: 3:58:20 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
2,424,343.879
398,215.677
-756,612.526
-6,629.320
37,283.625
Operating Cash Flow
--
398,215.677
-756,612.526
-6,629.320
37,283.625
Investing Cash Flow
-316,990.837
1,221,569.303
249,839.602
719,928.131
-2,173,763.860
Financing Cash Flow
-1,884,028.248
-1,210,172.083
329,564.162
-501,080.665
2,506,462.124
End Cash Position
1,981,103.878
1,765,644.712
1,319,707.186
1,479,633.434
1,330,245.256
Capital Expenditure
-310,315.196
-444,877.658
-222,421.477
-193,860.672
-212,489.968
Issuance of Debt
3,833,338.169
5,109,367.266
6,755,937.617
3,693,770.052
4,516,320.642
Repayment of Debt
-5,398,313.053
-5,991,710.831
-6,036,257.923
-3,730,561.544
-5,197,421.074
Free Cash Flow
2,114,028.684
-46,661.981
-979,034.003
-200,489.992
-175,206.343
12/31/2020 - 7/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers